Studies on the site of action of oral contraceptive steroids. I. Effect of antifertility steroids on plasma LH levels and on the response to luteinizing hormone-releasing factor in rats.
D000731:Androstanes / Q000494:pharmacology*; D000818:Animals; D002715:Chlormadinone Acetate / Q000494:pharmacology*; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004116:Dimethisterone / Q000494:pharmacology; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D005040:Ethynodiol Diacetate / Q000494:pharmacology*; D005260:Female; D007031:Hypothalamus / Q000187:drug effects; D007986:Luteinizing Hormone / Q000097:blood* / Q000378:metabolism; D008525:Medroxyprogesterone / Q000494:pharmacology*; D008656:Mestranol / Q000494:pharmacology*; D009640:Norethindrone / Q000494:pharmacology*; D009641:Norethynodrel / Q000494:pharmacology*; D010906:Pituitary Hormone-Releasing Hormones / Q000494:pharmacology*; D011372:Progestins / Q000494:pharmacology*; D051381:Rats
D000731:Androstanes; D003276:Contraceptives, Oral; D010906:Pituitary Hormone-Releasing Hormones; D011372:Progestins; D002715:Chlormadinone Acetate; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D009641:Norethynodrel; D007986:Luteinizing Hormone; D008656:Mestranol; D008525:Medroxyprogesterone; D004116:Dimethisterone; D009640:Norethindrone